@article{3a3e7ef6fb2b448db41ff3715cd274db,
title = "An approach to interventional pulmonary fellowship training",
abstract = "Interventional pulmonology continues to be a specialty that is experiencing an evolution of new technologies, with an emphasis on multidisciplinary care. The diversity and application of these procedures in patients with more complex conditions is leading to the need for more specific recommendations in training within this area. As patient safety and outcomes-based measures of clinical practice and procedures are in the forefront, the need for standardization in procedural training in high-volume centers of excellence beyond pulmonary and critical care fellowships must be considered. Other procedure-based specialties have developed such training programs, with structured curricula to enhance patient safety and outcomes, develop validated metrics for competency assessment of trainees, improve trainee education, and further advance the field by fostering research.",
author = "Lamb, {Carla R.} and David Feller-Kopman and Armin Ernst and Simoff, {Mike J.} and Sterman, {Daniel H.} and Wahidi, {Momen M.} and Kovitz, {Kevin L.}",
note = "Funding Information: Financial/nonfinancial disclosures: The authors have reported to CHEST the following conflicts of interest: Dr Lamb has received travel funds from Cardinal Health and SuperDimension Inc., and has participated in speaking activities for SuperDimension Inc., Boston Scientific, Alveolus, and Cook Medical. Dr Feller-Kopman holds a grant from Boston Scientific, serves as a consultant to Cardinal Health and Immersion Medical Inc., and has received lecture fees from SonoSite Inc. Dr Ernst has reported to CHEST that no potential conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article. Dr Simoff has served as a consultant to Olympus. Dr Sterman received travel costs from Spiration Inc. and consulted for Spiration Inc. and Brocus Technologies Inc. Dr Wahidi has received educational grants from Pentax, Olympus, Boston Scientific, and Bryan Inc.; has consulted for IPS Inc., Imersion Medical Inc., Cardinal Health, SuperDimension Inc., Care Fusion, and Veran Medical; and has participated in speaking activities for Axcan Pharma Inc. Dr Kovitz has received a grant from Spiration Inc. and travel funds from SuperDimension Inc., and has consulted for Broncus Technologies Inc. ",
year = "2010",
month = jan,
day = "1",
doi = "10.1378/chest.09-0494",
language = "English (US)",
volume = "137",
pages = "195--199",
journal = "CHEST",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "1",
}